234 related articles for article (PubMed ID: 7535723)
1. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties.
Gorai I; Nakazawa T; Miyagi E; Hirahara F; Nagashima Y; Minaguchi H
Gynecol Oncol; 1995 Apr; 57(1):33-46. PubMed ID: 7535723
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of six new human endometrial adenocarcinoma cell lines.
Möbus V; Gerharz CD; Mitze M; Moll R; Pollow K; Kother T; Knapstein PG; Kreienberg R
Gynecol Oncol; 1993 Mar; 48(3):370-83. PubMed ID: 7681807
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
4. Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.
Yanagibashi T; Gorai I; Nakazawa T; Miyagi E; Hirahara F; Kitamura H; Minaguchi H
Br J Cancer; 1997; 76(7):829-35. PubMed ID: 9328139
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.
Alama A; Barbieri F; Favre A; Cagnoli M; Noviello E; Pedullà F; Viale M; Foglia G; Ragni N
Gynecol Oncol; 1996 Jul; 62(1):82-8. PubMed ID: 8690298
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.
Scoles DR; Pavelka J; Cass I; Tran H; Baldwin RL; Armstrong K; Karlan BY
Gynecol Oncol; 2007 Jan; 104(1):120-8. PubMed ID: 16956650
[TBL] [Abstract][Full Text] [Related]
7. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
Bar JK; Harlozińska A
Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710
[TBL] [Abstract][Full Text] [Related]
8. Intermediate-sized filaments and specific markers in a human salivary gland adenocarcinoma cell line and its nude mouse tumors.
Sato M; Hayashi Y; Yanagawa T; Yoshida H; Yura Y; Azuma M; Ueno A
Cancer Res; 1985 Aug; 45(8):3878-90. PubMed ID: 2410104
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization.
Nishio J; Iwasaki H; Nabeshima K; Ishiguro M; Naumann S; Isayama T; Naito M; Kaneko Y; Kikuchi M; Bridge JA
Int J Oncol; 2005 Aug; 27(2):361-9. PubMed ID: 16010416
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
[TBL] [Abstract][Full Text] [Related]
11. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics.
Nilsson EE; Westfall SD; McDonald C; Lison T; Sadler-Riggleman I; Skinner MK
Cancer Chemother Pharmacol; 2002 Feb; 49(2):93-100. PubMed ID: 11862422
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
13. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
14. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
[TBL] [Abstract][Full Text] [Related]
15. Characterization and development of UCI 107, a primary human ovarian carcinoma cell line.
Gamboa G; Carpenter PM; Podnos YD; Dorion G; Iravani L; Bolton D; Mascarello JT; Manetta A
Gynecol Oncol; 1995 Sep; 58(3):336-43. PubMed ID: 7672698
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Verschraegen CF; Hu W; Du Y; Mendoza J; Early J; Deavers M; Freedman RS; Bast RC; Kudelka AP; Kavanagh JJ; Giovanella BC
Clin Cancer Res; 2003 Feb; 9(2):845-52. PubMed ID: 12576458
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.
Shenhua X; Lijuan Q; Hanzhou N; Xinghao N; Chihong Z; Gu Z; Weifang D; Yongliang G
J Exp Clin Cancer Res; 1999 Jun; 18(2):233-9. PubMed ID: 10464713
[TBL] [Abstract][Full Text] [Related]
19. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
[TBL] [Abstract][Full Text] [Related]
20. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
